Dr. Wroblewski is a board-certified ophthalmologist with an expertise in diseases of the retina, macula and vitreous. He’s a senior partner at Cumberland Valley Retina Consultants in Chambersburg, Pa.
The advisory board’s retinal ophthalmology experts give guidance on clinical programs, regulatory issues and more. Ohr’s leading drug candidate is Squalamine for neovascular ophthalmic clinical indications.
More Articles on Ophthalmology:
New Eyes in Las Vegas Hires Cornea Specialist Dr. Ksenia Stafeeva
Clearside Biomedical Appoints Dr. Glenn Noronha as Executive Vice President
Dr. John Ervin Elected President of Georgia Society of Ophthalmology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.